UPB - Upstream Bio, Inc.
8.39
-0.570 -6.794%
Share volume: 232,948
Last Updated: 04-25-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$8.96
-0.57
-0.06%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | |
| Report Date | 11-07-2024 | 03-12-2025 | |
| Assets | |||
| Total Assets | 232.700 M | 481.719 M | |
| Current Assets | 227.273 M | 479.160 M | |
| Inventories | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | |
| Short Term Investments | 187.711 M | 144.559 M | |
| Total Receivables | 0.000 | 0.000 | |
| Current Cash | 32.948 M | 325.892 M | |
| Total Non-current Assets | 0.000 | 0.000 | |
| Property Plant Equipment | 578.000 K | 582.000 K | |
| Other Assets | 4.849 M | 1.977 M | |
| Intangible Assets | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 232.700 M | 481.719 M | |
| Total liabilities | 12.137 M | 11.867 M | |
| Total current liabilities | 10.874 M | 10.737 M | |
| Accounts Payable | 4.899 M | 4.041 M | |
| Other liabilities | 1.263 M | 1.130 M | |
| Current long term debt | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | |
| Other liabilities | 1.263 M | 1.130 M | |
| Minority interest | 0.000 | 0.000 | |
| Total Shareholder equity | -160.311 M | 469.852 M | |
| Common stock | 8.876 M | 660.657 M | |
| Retained earnings | -169.538 M | -190.780 M |
